Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Holdenrieder

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Annals of the New York Academy of Sciences|July 15, 2004
Therapy control in oncology by circulating nucleosomesS Holdenrieder, P Stieber
Clinical Biochemistry|July 6, 2004
Apoptotic markers in cancerS Holdenrieder, P Stieber
Der Urologe. Ausg. A|October 15, 2014
[Detection of cell-free lncRNA in serum of cancer patients]K Kohls, D Schmidt, S Holdenrieder, et al.
British Journal of Cancer|April 13, 2013
Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancerS Boeck, C Wittwer, V Heinemann, et al.
Anticancer Research|September 2, 1999
Apoptosis in serum of patients with solid tumoursS Holdenrieder, P Stieber, T Förg, et al.
Clinical Chemistry and Laboratory Medicine|August 28, 2001
Nucleosomes in serum as a marker for cell deathS Holdenrieder, P Stieber, H Bodenmüller, et al.
Annals of the New York Academy of Sciences|November 16, 2001
Circulating nucleosomes in serumS Holdenrieder, P Stieber, H Bodenmüller, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 12, 2017
A comparison of gamma-glutamyl transferase and alkaline phosphatase as prognostic markers in patients with coronary heart diseaseG Ndrepepa, S Holdenrieder, S Cassese, et al.
Anticancer Research|May 18, 2012
Cytokeratin serum biomarkers in patients with colorectal cancerS Holdenrieder, P Stieber, V Liska, et al.
Anticancer Research|July 22, 2005
Changes of thymidine kinase (TK) during adjuvant and palliative chemotherapyO Topolcan, L Holubec, J Finek, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Annals of the New York Academy of Sciences|July 15, 2004
Therapy control in oncology by circulating nucleosomesS Holdenrieder, P Stieber
Clinical Biochemistry|July 6, 2004
Apoptotic markers in cancerS Holdenrieder, P Stieber
Der Urologe. Ausg. A|October 15, 2014
[Detection of cell-free lncRNA in serum of cancer patients]K Kohls, D Schmidt, S Holdenrieder, et al.
British Journal of Cancer|April 13, 2013
Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancerS Boeck, C Wittwer, V Heinemann, et al.
Anticancer Research|September 2, 1999
Apoptosis in serum of patients with solid tumoursS Holdenrieder, P Stieber, T Förg, et al.
Clinical Chemistry and Laboratory Medicine|August 28, 2001
Nucleosomes in serum as a marker for cell deathS Holdenrieder, P Stieber, H Bodenmüller, et al.
Annals of the New York Academy of Sciences|November 16, 2001
Circulating nucleosomes in serumS Holdenrieder, P Stieber, H Bodenmüller, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 12, 2017
A comparison of gamma-glutamyl transferase and alkaline phosphatase as prognostic markers in patients with coronary heart diseaseG Ndrepepa, S Holdenrieder, S Cassese, et al.
Anticancer Research|May 18, 2012
Cytokeratin serum biomarkers in patients with colorectal cancerS Holdenrieder, P Stieber, V Liska, et al.
Anticancer Research|July 22, 2005
Changes of thymidine kinase (TK) during adjuvant and palliative chemotherapyO Topolcan, L Holubec, J Finek, et al.
Pageof 2